ORGANIZATION

Plaintiffs, Lawyers Renew Opposition to Restart of HPV Vaccine Recommendation

October 13, 2021

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Plaintiffs of lawsuits over post-HPV-vaccination symptoms and their lawyers called an emergency gathering for lawmakers on October 12 to reiterate their opposition to the reinstatement of the government’s “active recommendation” for HPV vaccines. The gathering comes after two key health…

To read the full story

MSD Says to Ensure HPV Vaccine Supply in Japan, 4 Million-Plus Syringes for FY2022
March 30, 2022
MHLW Panel OKs Mix-and-Match HPV Vaccines in “Catch-Up” Program
January 31, 2022
Japan Panel OKs HPV “Catch-Up” Shots for Females Born in FY1997-FY2005
December 24, 2021
MSD Japan Hails Resumption of HPV Vaccine Recommendation
November 29, 2021
Japan Panel Agrees to Give Free “Catch-Up” HPV Shots
November 16, 2021
Plaintiffs, Lawyers Re-Stress Opposition to HPV Vaccine Recommendation
November 15, 2021
Japan to Reinstate HPV Vaccine Recommendation after 8 Years in Limbo
November 15, 2021
MHLW Health Service Chief Wants Prompt Debate on HPV Recommendation
October 20, 2021
LDP League Hails Start of Panel Discussions on HPV Vaccine Recommendation
October 13, 2021
No Factor to Impede Reinstatement of HPV Vaccine Recommendation: Panels
October 4, 2021
MHLW Panel to Discuss HPV Vaccine Recommendation on Oct. 1
September 29, 2021
Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
Regional Governors Club Urges Early Conclusion on HPV Vaccines
September 10, 2021
Plaintiffs of HPV Vaccine Suits Urge MHLW Not to Reinstate Recommendation
September 6, 2021
MSD Urges Govt to Start HPV Vaccine Discussions as Soon as Possible
September 2, 2021
Council to Discuss Resuming Active Recommendation of HPV Vaccines: Health Minister
September 1, 2021
Govt Recognizes Need to Resume HPV Vaccine Discussion: Health Minister
August 31, 2021
Govt Not Planning to Resume Active HPV Vaccine Recommendation before October: Minister
August 30, 2021
Reinstate Active HPV Vaccine Promotion before October: LDP League
August 27, 2021
Plaintiffs of HPV Vaccine Suits Urge LDP Group to Hear Stories of Sufferers
April 16, 2021
LDP League Submits Request to Reinstate HPV Vaccine Promotion
March 30, 2021
LDP Group to Submit Request for HPV Vaccine Promotion Resumption
March 26, 2021
Reinstate “Active Recommendation” for HPV Vaccines: LDP Lawmakers’ League
July 22, 2020

ORGANIZATION

EFPIA Report Calls Japan a “Cautionary Tale” in 10-Country Biopharma Strategy Review
March 2, 2026
Pharma Takes Harsh View of FY2026 Pricing Reform: Policy Group Survey
February 24, 2026
JPMA to Push Govt to Scrap Market-Based Drug Price Revisions
February 20, 2026
Pharma Group Looks to Growth Strategy under Takaichi after Election Win
February 10, 2026
Pharma Groups Call for Faster Diagnosis and R&D for Intractable, Rare Diseases
February 9, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…